Case report: Immunotherapy guided by molecular profiling of tumors: illustrative cases and literature review
Predictive biomarkers are necessary for the identification of immunotherapy-responsive patients. Tumor mutation burden (TMB), as determined by next-generation sequencing (NGS), and PD-L1 expression, as evaluated by Immunohistochemistry (IHC), are the biomarkers most frequently employed in clinical p...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2024-07-01
|
| Colección: | Frontiers in Medicine |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1403056/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|